Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

Brett Johnson, Tali Mazor, Chibo Hong et al. · Science · 2013 · 1.4K citations

Medicine, Genetics, Oncology +17

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

Martin J. van den Bent, D Afra, Olivier De Witte et al. · The Lancet · 2005 · 1K citations

Medicine, Oncology, Radiation Oncology +17

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

Daniel J. Brat, Kenneth Aldape, Howard Colman et al. · Acta Neuropathologica · 2018 · 906 citations

Medicine, Neurology, Oncology +15

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Brigitta G. Baumert, Monika E. Hegi, Martin J. van den Bent et al. · The Lancet Oncology · 2016 · 498 citations · Full text

Medicine, Oncology, Pharmacology +16

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

Felix Sahm, Daniel Schrimpf, Benedikt Wiestler et al. · Acta Neuropathologica · 2014 · 446 citations · Full text

Medicine, Oncology, Pathology +17